Clinical Trials Directory

Trials / Completed

CompletedNCT01418248

Study of Exercise and Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease

Evaluation of Exercise Intolerance and Right Heart Function in Patients With Heart Failure and Pulmonary Vascular Disease

Status
Completed
Phase
Study type
Observational
Enrollment
108 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Heart Failure with Preserved Ejection Fraction (HFpEF) and Pulmonary Hypertension (PH) can be diagnosed noninvasively by Exercise Echocardiography (ExE) and Cardiopulmonary Exercise Testing (CPX) as compared with gold standard invasive hemodynamic assessment.

Detailed description

* The broad objective of this proposal is to characterize the dynamic changes in cardiopulmonary mechanics during stress in patients with exertional dyspnea, establishing a comprehensive multimodality diagnostic approach to the evaluation of exercise intolerance. * The specific objective is to prospectively compare established and novel parameters derived from echocardiography and CPX with simultaneous, gold standard invasive measures of cardiovascular hemodynamics at rest and with exercise stress to define the role of noninvasive testing in the diagnostic workup. * The primary hypothesis is that combined ExE and CPX can noninvasively identify HFpEF.

Conditions

Timeline

Start date
2011-08-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2011-08-17
Last updated
2014-01-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01418248. Inclusion in this directory is not an endorsement.